The down-regulation of pathways in cancer is noteworthy, particularly given that thymidine phosphorylase is upregulated across a broad spectrum of solid tumours, where its elevated expression is associated with increased tumour growth, metastasis, angiogenesis, and poor prognosis. The gene discussed is TYMP; the disease is cancer.